SEARCH

SEARCH BY CITATION

References

  • 1
    Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351:12251232.
  • 2
    Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med 2005;352:23142324.
  • 3
    Fanta CH. Asthma. N Engl J Med 2009;360:10021014.
  • 4
    Bieber T. Atopic dermatitis. N Engl J Med 2008;358:14831494.
  • 5
    Schmitt J, Schmitt NM, Kirch W, Meurer M. Outpatient care and medical treatment of children and adults with atopic eczema. J Dtsch Dermatol Ges 2009;7:345351.
  • 6
    Smaldone A, Honig JC, Byrne MW. Sleepless in America: inadequate sleep and relationships to health and well-being of our nation’s children. Pediatrics 2007;119(Suppl 1):S29S37.
  • 7
    O’Connell EJ. The burden of atopy and asthma in children. Allergy 2004;59(Suppl 78):711.
  • 8
    Fivenson D, Arnold RJ, Kaniecki DJ, Cohen JL, Frech F, Finlay AY. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J Manag Care Pharm 2002;8:333342.
  • 9
    Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003;6(Suppl):S118S127.
  • 10
    Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006;60:984992.
  • 11
    Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH et al. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007;120:396402.
  • 12
    Vandenplas O, Dramaix M, Joos G, Louis R, Michils A, Verleden G et al. The impact of concomitant rhinitis on asthma-related quality of life and asthma control. Allergy 2010;Epub ahead of print. DOI: 10.1111/j.1398-9995.2010.02365.x.
  • 13
    Schmitt J, Romanos M, Pfennig A, Leopold K, Meurer M. Psychiatric comorbidity in adult eczema. Br J Dermatol 2009;161:878883.
  • 14
    Wilson DH, Appleton SL, Taylor AW, Tucker G, Ruffin RE, Wittert G et al. Depression and obesity in adults with asthma: multiple comorbidities and management issues. Med J Aust 2010;192:381383.
  • 15
    Timonen M, Jokelainen J, Hakko H, Silvennoinen-Kassinen S, Meyer-Rochow VB, Herva A et al. Atopy and depression: results from the Northern Finland 1966 Birth Cohort Study. Mol Psychiatry 2003;8:738744.
  • 16
    Yang TO, Lunt I, Sylva K. Peer stress-related coping activities in young adolescents’ asthma management. J Asthma 2009;46:613617.
  • 17
    Williams DR, Sternthal M, Wright RJ. Social determinants: taking the social context of asthma seriously. Pediatrics 2009;123(Suppl 3):S174S184.
  • 18
    Arndt J, Smith N, Tausk F. Stress and atopic dermatitis. Curr Allergy Asthma Rep 2008;8:312317.
  • 19
    Schmid-Ott G, Burchard R, Niederauer HH, Lamprecht F, Kunsebeck HW. [Stigmatization and quality of life of patients with psoriasis and atopic dermatitis]. Hautarzt 2003;54:852857.
  • 20
    Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe – a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 2005;15:357376.
  • 21
    Eaton WW, Martins SS, Nestadt G, Bienvenu OJ, Clarke D, Alexandre P. The burden of mental disorders. Epidemiol Rev 2008;30:114.
  • 22
    Belfer ML. Child and adolescent mental disorders: the magnitude of the problem across the globe. J Child Psychol Psychiatry 2008;49:226236.
  • 23
    Polanczyk G, Silva de Lima MS, Horta BL, Biederman J, Rhode LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007;164:942948.
  • 24
    Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005;366:237248.
  • 25
    Cuffe SP, Moore CG, McKeown R. ADHD and health services utilization in the national health interview survey. J Atten Disord 2009;12:330340.
  • 26
    Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA et al. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin 2005;21:195206.
  • 27
    De Graaf R, Kessler RC, Fayyad J, Ten Have M, Alonso J, Angermeyer M et al. The prevalence and effects of Adult Attention-Deficit/hyperactivity Disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med 2008;65:835842.
  • 28
    Cortese S, Konofal E, Yateman N, Mouren MC, Lecendreux M. Sleep and alertness in children with attention-deficit/hyperactivity disorder: a systematic review of the literature. Sleep 2006;29:504511.
  • 29
    Paavonen EJ, Raikkonen K, Lahti J, Komsi N, Heinonen K, Pesonen AK et al. Short sleep duration and behavioral symptoms of attention-deficit/hyperactivity disorder in healthy 7- to 8-year-old children. Pediatrics 2009;123:e857e864.
  • 30
    Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med 2006;36:167179.
  • 31
    Roth N. A link between atopic and behavioral disorders: indirect evidence from stimulant drug effects. Allergy 1990;45:316317.
  • 32
    Mrazek DA. Psychiatric symptoms in patients with asthma causality, comorbidity, or shared genetic etiology. Child Adolesc Psychiatr Clin N Am 2003;12:459471.
  • 33
    Marshall P. Attention deficit disorder and allergy: a neurochemical model of the relation between the illnesses. Psychol Bull 1989;106:434446.
  • 34
    Stevenson J. Relationship between behavior and asthma in children with atopic dermatitis. Psychosom Med 2003;65:971975.
  • 35
    Geschwind N, Behan P. Left-handedness: association with immune disease, migraine, and developmental learning disorder. Proc Natl Acad Sci USA 1982;79:50975100.
  • 36
    Pennington BF, Smith SD, Kimberling WJ, Green PA, Haith MM. Left-handedness and immune disorders in familial dyslexics. Arch Neurol 1987;44:634639.
  • 37
    Biederman J, Milberger S, Faraone SV, Lapey KA, Reed ED, Seidman LJ. No confirmation of Geschwind’s hypothesis of associations between reading disability, immune disorders, and motor preference in ADHD. J Abnorm Child Psychol 1995;23:545552.
  • 38
    Gaitens T, Kaplan BJ, Freigang B. Absence of an association between IgE-mediated atopic responsiveness and ADHD symptomatology. J Child Psychol Psychiatry 1998;39:427431.
  • 39
    Hammerness P, Monuteaux MC, Faraone SV, Gallo L, Murphy H, Biederman J. Reexamining the familial association between asthma and ADHD in girls. J Atten Disord 2005;8:136143.
  • 40
    Schmitt J, Romanos M, Schmitt NM, Meurer M, Kirch W. Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents. JAMA 2009;301:724726.
  • 41
    Romanos M, Gerlach M, Warnke A, Schmitt J. Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 2010;64:269273.
  • 42
    Schmitt J, Apfelbacher C, Chen CM, Romanos M, Sausenthaler S, Koletzko S et al. Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus). J Allergy Clin Immunol 2010;125:404410.
  • 43
    Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832836.
  • 44
    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:20082012.
  • 45
    Spencer TJ, Biederman J, Mick E. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J Pediatr Psychol 2007;32:631642.
  • 46
    Zhang S, Faries DE, Vowles M, Michelson D. ADHD Rating Scale IV: psychometric properties from a multinational study as a clinician-administered instrument. Int J Methods Psychiatr Res 2005;14:186201.
  • 47
    Roessner V, Becker A, Rothenberger A, Rohde LA, Banaschewski T. A cross-cultural comparison between samples of Brazilian and German children with ADHD/HD using the Child Behavior Checklist. Eur Arch Psychiatry Clin Neurosci 2007;257:352359.
  • 48
    Thapar A, Langley K, O’donovan M, Owen M. Refining the attention deficit hyperactivity disorder phenotype for molecular genetic studies. Mol Psychiatry 2006;11:714720.
  • 49
    Schmitt J, Romanos M. Lack of studies investigating the association of childhood eczema, sleeping problems, and attention-deficit/hyperactivity disorder. Pediatr Allergy Immunol 2009;20:299300.
  • 50
    Stata Corporation. Stata 8 Reference Manual. College Station, TX: Stata Corporation 2003.
  • 51
    Cutuli JJ, Herbers JE, Rinaldi M, Masten AS, Oberg CN. Asthma and behavior in homeless 4- to 7-year-olds. Pediatrics 2010;125:145151.
  • 52
    Hysing M, Elgen I, Gillberg C, Lundervold AJ. Emotional and behavioural problems in subgroups of children with chronic illness: results from a large-scale population study. Child Care Health Dev 2009;35:527533.
  • 53
    De Vries TW, Van Roon EN, Duiverman EJ. Inhaled corticosteroids do not affect behaviour. Acta Paediatr 2008;97:786789.
  • 54
    Yuksel H, Sogut A, Yilmaz O. Attention deficit and hyperactivity symptoms in children with asthma. J Asthma 2008;45:545547.
  • 55
    Blackman JA, Gurka MJ. Developmental and behavioral comorbidities of asthma in children. J Dev Behav Pediatr 2007;28:9299.
  • 56
    Infante M, Slattery MJ, Klein MH, Essex MJ. Association of internalizing disorders and allergies in a child and adolescent psychiatry clinical sample. J Clin Psychiatry 2007;68:14191425.
  • 57
    Calam R, Gregg L, Goodman R. Psychological adjustment and asthma in children and adolescents: the UK Nationwide Mental Health Survey. Psychosom Med 2005;67:105110.
  • 58
    Secnik K, Swensen A, Lage MJ. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics 2005;23:93102.
  • 59
    Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O’Brien PC. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA 2001;285:6066.
  • 60
    O’Callaghan MJ, Harvey JM. Biological predictors and co-morbidity of attention deficit and hyperactivity disorder in extremely low birthweight infants at school. J Paediatr Child Health 1997;33:491496.
  • 61
    Flannery KA, Liederman J. Is there really a syndrome involving the co-occurrence of neurodevelopmental disorder talent, non-right handedness and immune disorder among children? Cortex 1995;31:503515.
  • 62
    McGee R, Stanton WR, Sears MR. Allergic disorders and attention deficit disorder in children. J Abnorm Child Psychol 1993;21:7988.
  • 63
    Blank R, Remschmidt H. Subgruppen hyperkinetischer Störungen - explorative Untersuchungen unter Berücksichtigung von Fragebogenverfahren und immunologischen Parametern. Z Kinder-Jugendpsychiatr 1992;20:3445.
  • 64
    Beyreiss J, Roth N, Beyer H, Kropf S, Shlenzka K, Schmidt A et al. Coincidence of immune (atopic dermatitis) and behavioral (attention deficit) disorders in children: empirical data. Act Nerv Super (Praha) 1988;30:127128.
  • 65
    Arbeitsgruppe Erhebung und Nutzung von Sekundärdaten (AGENS) der Deutschen Gesellschaft für Sozialmedizin und Prävention (DGSMP). Gute Praxis Sekundärdatenanalyse (GPS). In: SwartE, IhleP, editors. Routinedaten im Gesundheitswesen – Handbuch Sekundärdatenanalyse: Grundlagen, Methoden und Perspektiven. Bern: Verlag Hans Huber 2005: 405412.
  • 66
    Köster I, Von Ferber L. Interne Diagnosevalidierung. In: Von FerberL, BehrensJ, editors. Public Health Forschung mit Gesundheits- und Sozialdaten. Stand und Perspektiven. Sankt Augustin: Asgard-Verlag 1997: 5564.
  • 67
    Szklo M, Nieto J. Epidemiology Beyond the Basics. Sidbury, Massachusetts: Jones and Barlett Publishers 2005.
  • 68
    Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ et al. The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994;131:383396.
  • 69
    Muris P, Meesters C, Van Den BF. The Strengths and Difficulties Questionnaire (SDQ) – further evidence for its reliability and validity in a community sample of Dutch children and adolescents. Eur Child Adolesc Psychiatry 2003;12:18.
  • 70
    Achenbach TM, Becker A, Dopfner M, Heiervang E, Roessner V, Steinhausen HC et al. Multicultural assessment of child and adolescent psychopathology with ASEBA and SDQ instruments: research findings, applications, and future directions. J Child Psychol Psychiatry 2008;49:251275.
  • 71
    Goodman R, Ford T, Richards H, Gatward R, Meltzer H. The Development and Well-Being Assessment: description and initial validation of an integrated assessment of child and adolescent psychopathology. J Child Psychol Psychiatry 2000;41:645655.
  • 72
    DuPaul GJ. Parent and teacher ratings of ADHD symptoms: psychometric properties in a community-based sample. J Clin Child Psychol 1991;20:245253.
  • 73
    Rutter M, Tizard J, Whitmore K. Education, Health and Behaviour. London: Longmans 1970.
  • 74
    Conners CK. Conners’ Rating Scales-Revised. North Toawada: Multi-Health Systems Publishing 1997.
  • 75
    Essex MJ, Boyce WT, Goldstein LH, Armstrong JM, Kraemer HC, Kupfer DJ. The confluence of mental, physical, social, and academic difficulties in middle childhood. II: developing the Macarthur health and Behavior Questionnaire. J Am Acad Child Adolesc Psychiatry 2002;41:588603.
  • 76
    Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington DC: American Psychiatric Association 2000.
  • 77
    Yarlagadda A, Alfson E, Clayton AH. The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry (Edgmont) 2009;6:1822.
  • 78
    Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:2431.
  • 79
    Tonelli LH, Katz M, Kovacsics CE, Gould TD, Joppy B, Hoshino A et al. Allergic rhinitis induces anxiety-like behavior and altered social interaction in rodents. Brain Behav Immun 2009;23:784793.
  • 80
    Basso AS, Pinto FA, Russo M, Britto LR, Sa-Rocha LC, Palermo NJ. Neural correlates of IgE-mediated food allergy. J Neuroimmunol 2003;2:6977.
  • 81
    Rosenkranz MA, Busse WW, Johnstone T, Swenson CA, Crisafi GM, Jackson MM et al. Neural circuitry underlying the interaction between emotion and asthma symptom exacerbation. Proc Natl Acad Sci USA 2005;102:1331913324.
  • 82
    Goto Y, Yang CR, Otani S. Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders. Biol Psychiatry 2010;67:199207.
  • 83
    Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB Jr, Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005;22:192199.
  • 84
    Rosenblum LA, Smith EL, Altemus M, Scharf BA, Owens MJ, Nemeroff CB et al. Differing concentrations of corticotropin-releasing factor and oxytocin in the cerebrospinal fluid of bonnet and pigtail macaques. Psychoneuroendocrinology 2002;27:651660.
  • 85
    Sanchez MM, Noble PM, Lyon CK, Plotsky PM, Davis M, Nemeroff CB et al. Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing. Biol Psychiatry 2005;57:373381.
  • 86
    Sanchez MM, Ladd CO, Plotsky PM. Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models. Dev Psychopathol 2001;13:419449.
  • 87
    Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry 2001;158:575581.
  • 88
    De Bellis MD, Lefter L, Trickett PK, Putnam FW Jr, . Urinary catecholamine excretion in sexually abused girls. J Am Acad Child Adolesc Psychiatry 1994;33:320327.
  • 89
    Engert V, Joober R, Meaney MJ, Hellhammer DH, Pruessner JC. Behavioral response to methylphenidate challenge: influence of early life parental care. Dev Psychobiol 2009;51:408416.
  • 90
    Ednick M, Cohen AP, McPhail GL, Beebe D, Simakajornboon N, Amin RS. A review of the effects of sleep during the first year of life on cognitive, psychomotor, and temperament development. Sleep 2009;32:14491458.
  • 91
    Weissbluth M. Sleep duration and infant temperament. J Pediatr 1981;99:817819.
  • 92
    Kayani S, Shannon DC. Adverse behavioral effects of treatment for acute exacerbation of asthma in children: a comparison of two doses of oral steroids. Chest 2002;122:624628.
  • 93
    Snyder SM, Hall JR, Cornwell SL, Quintana H. Review of clinical validation of ADHD behavior rating scales. Psychol Rep 2006;99:363378.
  • 94
    Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry 1998;59(Suppl 7):5058.
  • 95
    Systematic reviews in health care. Meta-analysis in context, 3rd edn. London: BMJ Publishing Group 2003.
  • 96
    Weidinger S, O’Sullivan M, Illig T, Baurecht H, Depner M, Rodriguez E et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 2008;121:12031209.
  • 97
    Romanos M, Freitag C, Jacob C, Craig DW, Dempfle A, Nguyen TT et al. Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12. Mol Psychiatry 2008;13:522530.
  • 98
    Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Arch Dermatol 2004;140:15131519.